SG11202105172PA - Biomarkers for cardiovascular events - Google Patents
Biomarkers for cardiovascular eventsInfo
- Publication number
- SG11202105172PA SG11202105172PA SG11202105172PA SG11202105172PA SG11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA
- Authority
- SG
- Singapore
- Prior art keywords
- biomarkers
- cardiovascular events
- cardiovascular
- events
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/04—Phospholipids, i.e. phosphoglycerides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/08—Sphingolipids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862776272P | 2018-12-06 | 2018-12-06 | |
PCT/EP2019/084008 WO2020115288A1 (en) | 2018-12-06 | 2019-12-06 | Biomarkers for cardiovascular events |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202105172PA true SG11202105172PA (en) | 2021-06-29 |
Family
ID=68808396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202105172PA SG11202105172PA (en) | 2018-12-06 | 2019-12-06 | Biomarkers for cardiovascular events |
Country Status (8)
Country | Link |
---|---|
US (1) | US20220003791A1 (en) |
EP (1) | EP3891509A1 (en) |
JP (1) | JP2022508322A (en) |
KR (1) | KR20210100679A (en) |
CN (1) | CN113396334A (en) |
CA (1) | CA3122035A1 (en) |
SG (1) | SG11202105172PA (en) |
WO (1) | WO2020115288A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016123163A2 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
EP4043884A1 (en) | 2021-02-10 | 2022-08-17 | Eberhard-Karls-Universität Tübingen | Medium-chain fatty acyls and phospholipids as biomarkers for cardiovascular diseases |
US11735303B2 (en) * | 2021-06-22 | 2023-08-22 | David Haase | Apparatus and method for determining a composition of a replacement therapy treatment |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9066939B2 (en) * | 2009-11-17 | 2015-06-30 | Baylor Research Institute | Urinary triaosylceramide (GB3) as a marker of cardiac disease |
ES2455124T5 (en) * | 2010-05-05 | 2018-05-08 | Zora Biosciences Oy | Lipidomic biomarkers for atherosclerosis and heart disease |
CN103154742B (en) | 2010-06-20 | 2017-11-21 | 佐拉生物科学公司 | For identifying the iipidomic mark of excessive risk patients with coronary artery disease |
EP2592422A1 (en) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment |
EP2592423A1 (en) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment |
US20160018423A1 (en) * | 2013-03-08 | 2016-01-21 | Zora Biosciences Oy | Non-high density lipoprotein derived cvd markers |
KR101565889B1 (en) * | 2014-04-23 | 2015-11-06 | 연세대학교 산학협력단 | Methods for Predicting or Determining Arterial Stiffness Using plasma metabolites |
US9347960B2 (en) * | 2014-06-16 | 2016-05-24 | Zora Biosciences, Oy | Ceramides and their use in diagnosing CVD |
CA3013316A1 (en) * | 2016-02-04 | 2017-08-10 | Metanomics Gmbh | Means and methods for differentiating between heart failure and pulmonary disease in a subject |
-
2019
- 2019-12-06 CA CA3122035A patent/CA3122035A1/en active Pending
- 2019-12-06 CN CN201980091282.1A patent/CN113396334A/en active Pending
- 2019-12-06 US US17/295,139 patent/US20220003791A1/en active Pending
- 2019-12-06 KR KR1020217021198A patent/KR20210100679A/en unknown
- 2019-12-06 WO PCT/EP2019/084008 patent/WO2020115288A1/en unknown
- 2019-12-06 SG SG11202105172PA patent/SG11202105172PA/en unknown
- 2019-12-06 EP EP19816678.7A patent/EP3891509A1/en active Pending
- 2019-12-06 JP JP2021531869A patent/JP2022508322A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2022508322A (en) | 2022-01-19 |
CA3122035A1 (en) | 2020-06-11 |
CN113396334A (en) | 2021-09-14 |
US20220003791A1 (en) | 2022-01-06 |
WO2020115288A1 (en) | 2020-06-11 |
KR20210100679A (en) | 2021-08-17 |
EP3891509A1 (en) | 2021-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202105172PA (en) | Biomarkers for cardiovascular events | |
GB201704267D0 (en) | Novel biomarker | |
GB201703058D0 (en) | Biomarkers | |
GB2596456B (en) | Immunoassay for mitragynine | |
GB201908780D0 (en) | Melanoma biomarkers | |
GB201902077D0 (en) | Biomarkers | |
GB201911947D0 (en) | Miscarriage biomarkers | |
GB201804648D0 (en) | Combination biomarker | |
GB201703123D0 (en) | Biomarkers | |
GB201900677D0 (en) | Biomarkers | |
GB201909228D0 (en) | Screen for inhibitors | |
GB201814807D0 (en) | Dementia Biomarkers | |
GB201811093D0 (en) | Biomarker | |
GB201706064D0 (en) | Biomarkers for glucocorticoid action | |
SG11202110589PA (en) | Biomarkers for selinexor | |
EP3807614C0 (en) | Microtome | |
PL3894133T3 (en) | An electrospindle | |
PT3894132T (en) | An electrospindle | |
GB201915228D0 (en) | Biomarkers | |
GB201902070D0 (en) | Biomarkers | |
GB201914183D0 (en) | Biomarker | |
GB201913846D0 (en) | Biomarker | |
GB201913612D0 (en) | Biomarker | |
GB201912154D0 (en) | Biomarker | |
GB201911078D0 (en) | Biomarker |